$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Neuromodulation uses low-amplitude electrical stimulation to alter the function of the end organ1. In the context of lower urinary tract dysfunction, such as overactive bladder syndrome (OAB), non-obstructive urinary retention, neurogenic bladder, and bladder pain syndrome, neuromodulation is employed as a third-line treatment for patients who failed behavioral therapy and pharmacotherapy2. For neuromodulation in patients with OAB, posterior tibial nerve stimulation and sacral nerve stimulation (SNS) have been widely used in clinical practice. Experimental neuromodulation approaches targeting additional peripheral nerves, including the pudendal and peroneal nerves, are being studied3,4,5,6.
Although neuromodulation has been used in the treatment of bladder and bowel disease for several decades, its mechanism of action is not fully understood. As stated in the multidisciplinary expert group review, currently used stimulation parameters were mostly chosen by manufacturers based on a trial-and-error approach7. It is therefore important to continue using animal models to elucidate underlying pathways and optimize stimulation parameters to improve therapeutic effect. Several preclinical experiments have been conducted, using awake and anesthetized animals, including mice, rats, sheep, dogs, and cats4. With ethical guidelines and research policies worldwide encouraging the use of less complex, smaller species, rodent models have been employed most frequently in recent years.
SNS in rat models of bladder dysfunction has predominantly employed two methodological approaches. The first, described by Zvara et al., involves implanting a stimulating electrode into the sacral foramen using an angiocatheter or a spinal needle8. The second approach requires the exposure of the L6 nerve root and positioning stimulating electrodes under the L6 nerves, with silicone glue used to secure the contact between the electrode and the nerve9. The technique involving electrode placement in sacral foramen mirrors the clinical approach. The method using exposure of the L6 root, while technically challenging, provides precise localization and more consistent access to the nerve.
Rat animal models mimicking the posterior tibial nerve stimulation have been described in the literature. Most frequently used method involves surgical exposure of the tibial nerve on the medial aspect of the hindlimb above the ankle10,11,12,13,14,15,16. Another method consists of percutaneous insertion of needle electrodes near the tibial nerve17. This article aims to provide a detailed description of tibial nerve stimulation at its origin, between the gluteus maximus and biceps femoris muscles, where the sciatic nerve splits into three branches: the tibial, common peroneal, and sural nerves. In addition, this study introduces peroneal nerve stimulation as a novel animal model for investigating a new neuromodulation method. The translational relevance of this rat model is supported by the recent clinical introduction of peroneal nerve stimulation for bladder neuromodulation18,19.